CCL21 and breast carcinoma: We demonstrate here that CCR7 activation by CCL21 binding can induce a significant increase in both AKT and ERK1/2 phosphorylation in breast cancer cells; however, only the former pathway is required for VEGF-C up-regulation and secretion.